#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in liver Craniopharyngioma Primary amyloidosis Arteriosclerosis Hodgkin's disease Cold type haemolytic anaemia Non-small cell lung cancer metastatic Mucopolysaccharidosis II Bronchopulmonary dysplasia Medulloblastoma Myelodysplastic syndrome with excess blasts Hypertriglyceridaemia Metastatic gastric cancer Malignant melanoma Crohn's disease More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS Nodal marginal zone B-cell lymphoma – Diagnostics Fragile X syndrome Cystic fibrosis lung Amyotrophic lateral sclerosis – Life with Disease Mantle cell lymphoma stage III – Treatment Anaplastic thyroid cancer – Life with Disease Hyperoxaluria – Treatment Erdheim-Chester disease – Life with Disease Mantle cell lymphoma refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imiquimod Fosinopril Sodium Aminohippuric Acid Omp12 Entinostat Repotrectinib Oric-114 Varnimcabtagene Autoleucel Vancomycin Deutivacaftor Satralizumab Lamotrigine Ruxotemitide Fazirsiran Pimecrolimus Allopurinol Amsacrine SIGVOTATUG VEDOTIN Linperlisib Ceftazidime More therapies…

    Learn about Your Condition

    Vascular graft thrombosis Peripheral spondyloarthritis Schizoaffective disorder Mastocytosis Penile cancer Thyroidectomy Post procedural hypotension Bipolar disorder Dermatomyositis Carotid artery stenosis Familial mediterranean fever Heart transplant Premature baby Mitochondrial myopathy Pituitary tumour benign More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hereditary haemorrhagic telangiectasia
    Belgium Bulgaria France Germany Hungary Italy +3

  • Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Crd-4730
    Bulgaria Czechia Hungary Italy Latvia Lithuania +4

  • ELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Bulgaria Czechia Hungary The Netherlands Poland Spain

  • Study of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Czechia Germany Greece Italy Latvia +2

  • KAI-9531 in Adults With Obesity or Overweight and Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • HRS 9531
    Bulgaria Czechia Germany Hungary Poland Spain

  • A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

    Not yet recruiting

    2 1
    Investigated Drugs:
    • ZAMPILIMAB
    Belgium Bulgaria Czechia France Germany Italy +5

  • A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Study Comparing Rezvilutamide and Bicalutamide with Hormone Therapy for Patients with Advanced Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    • Rezvilutamide
    • Goserelin
    Bulgaria Czechia Poland

  • Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaemia of chronic disease
    Investigated Drugs:
    • Darbepoetin Alfa
    • Efepoetin Alfa
    Bulgaria Czechia Hungary Italy Poland

  • Study on How Gadoquatrane Works and Its Safety in Children Undergoing MRI Scans

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Magnetic resonance imaging
    Investigated Drugs:
    • Gadoquatrane
    Bulgaria Czechia Germany Hungary Italy Poland +1
Previous Page
1 … 7 8 9 10 11 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!